	自己資本および準備金		日付
Acadia Pharmaceuticals	USD 917.27M	94.89M	2025-09
Adma Biologics	USD 431.19M	32.87M	2025-09
ALKERMES	USD 1.82B	85.86M	2025-12
Alterity Therapeutics Limited	AUD 22.81M	5.29M	2023-06
AstraZeneca	USD 48.67B	2.78B	2025-12
BioCryst Pharmaceuticals	USD -387.89M	33.7M	2025-09
Bristol-Myers Squibb	USD 18.55B	1.06B	2025-09
Cipla	INR 329.19B	16.3B	2025-09
Clal Biotechnology	ILS 121.41M	4.62M	2023-12
Compugen	USD 43.83M	6.43M	2025-09
CSL	USD 18.66B	2.75B	2025-12
Eli Lilly	USD 26.54B	2.74B	2025-12
Esperion Therapeutics	USD -451.36M	17.85M	2025-09
GlaxoSmithKline	GBP 16.38B	229M	2025-12
Grifols	EUR 6.08B	34.72M	2025-09
Halozyme Therapeutics	USD 48.81M	455.1M	2025-12
Ionis Pharmaceuticals	USD 617.97M	13.76M	2025-09
J&J	USD 78.47B	0	2025-09
Merck	USD 51.85B	2.79B	2025-09
Minerva Neurosciences	USD -34.58M	2.47M	2025-09
Neurocrine Biosciences	USD 3.25B	249.5M	2025-12
Novartis	USD 44.75B	2.7B	2025-09
Novavax	USD -156.67M	194.3M	2025-09
Pfizer	USD 92.8B	4.11B	2025-09
Roche Holding	CHF 33.8B	758M	2025-12
Sanofi	EUR 71.71B	1.55B	2025-12
Takeda	JPY 7.64T	513.39B	2025-12
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12